Business Wise Exclusive Columns Indian Government Business Today
Business Today
Business Wise by Rajeev Dubey
Sleepy drug regulators mute witness to Covid vaccine one-upmanship; leave investors, patients at grave risk

Emboldened, firms indulge in a game of one-upmanship based on alarmingly low number of trials. Sputnik had been tried on only 20 patients before Gamaleya made the claim; Pfizer 120 and Moderna 95

There are no ifs and buts about this one. India is well and truly in the grip of a slowdown that is threatening to get worse by the day
The furore against the supposed unprecedented move forced the ministry of finance to issue a clarification which cleverly didn't mention Section 7.
Frightful and irresponsible commentaries about a 'systemic risk' suggesting India's financial system could collapse due to IL&FS have added fuel to fire
Such defiance is unprecedented. But FinMin and the RBI are playing wink-wink in the name of  institutional independence. Hey, haven't we heard that before!
It would be near impossible to fabricate such a vast record of meetings and discussions as well as minutes of meetings at both the Indian and French end.
The Centre has been nervous ever since the markets began gyrating to the rumours of an imminent collapse among NBFCs, particularly housing finance companies